Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Rowland

Showing results (121-130 of 155) with videos related to

Pageof 16
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2009
Presence of a multidrug-resistance mutation in an HIV-2 variant infecting a treatment-naive individual in Caio, Guinea BissauSabelle Jallow, Tim Vincent, Aleksandra Leligdowicz, et al.
Omics : a Journal of Integrative Biology|December 9, 2016
KIR Gene Content Diversity in a Zimbabwean Population: Does KIR2DL2 Have a Role in Protection Against Human Immunodeficiency Virus Infection?Kudakwashe Mhandire, Lynn Sodai Zijenah, Louis-Marie Yindom, et al.
The Lancet. Child & Adolescent Health|May 4, 2020
Chronic comorbidities in children and adolescents with perinatally acquired HIV infection in sub-Saharan Africa in the era of antiretroviral therapyLisa J Frigati, Wole Ameyan, Mark F Cotton, et al.
AIDS (London, England)|October 4, 2012
Population dynamics of HIV-2 in rural West Africa: comparison with HIV-1 and ongoing transmission at the heart of the epidemicThushan I de Silva, Carla van Tienen, Clayton Onyango, et al.
Plos One|August 7, 2008
Maintenance of large subpopulations of differentiated CD8 T-cells two years after cytomegalovirus infection in Gambian infantsDavid J C Miles, Marianne van der Sande, David Jeffries, et al.
AIDS Research and Human Retroviruses|December 9, 2004
Construction of an infectious HIV type 1 molecular clone from an African patient with a subtype D/C Recombinant VirusBinshan Shi, Sean M Philpott, Barbara Weiser, et al.
Trials|January 27, 2022
Vitamin D<sub>3</sub> and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trialNyasha Veronica Dzavakwa, Molly Chisenga, Grace McHugh, et al.
Trials|July 22, 2024
Update: Vitamin D<sub>3</sub> and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trialNyasha Veronica Dzavakwa, Molly Chisenga, Grace McHugh, et al.
Virology Journal|January 30, 2021
Role of antenatal plasma cytomegalovirus DNA levels on pregnancy outcome and HIV-1 vertical transmission among mothers in the University of Zimbabwe birth cohort study (UZBCS)Kerina Duri, Simbarashe Chimhuya, Exnevia Gomo, et al.
Vaccine|September 24, 2005
Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteersInese Cebere, Lucy Dorrell, Helen McShane, et al.
Pageof 16

Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2009
Presence of a multidrug-resistance mutation in an HIV-2 variant infecting a treatment-naive individual in Caio, Guinea BissauSabelle Jallow, Tim Vincent, Aleksandra Leligdowicz, et al.
Omics : a Journal of Integrative Biology|December 9, 2016
KIR Gene Content Diversity in a Zimbabwean Population: Does KIR2DL2 Have a Role in Protection Against Human Immunodeficiency Virus Infection?Kudakwashe Mhandire, Lynn Sodai Zijenah, Louis-Marie Yindom, et al.
The Lancet. Child & Adolescent Health|May 4, 2020
Chronic comorbidities in children and adolescents with perinatally acquired HIV infection in sub-Saharan Africa in the era of antiretroviral therapyLisa J Frigati, Wole Ameyan, Mark F Cotton, et al.
AIDS (London, England)|October 4, 2012
Population dynamics of HIV-2 in rural West Africa: comparison with HIV-1 and ongoing transmission at the heart of the epidemicThushan I de Silva, Carla van Tienen, Clayton Onyango, et al.
Plos One|August 7, 2008
Maintenance of large subpopulations of differentiated CD8 T-cells two years after cytomegalovirus infection in Gambian infantsDavid J C Miles, Marianne van der Sande, David Jeffries, et al.
AIDS Research and Human Retroviruses|December 9, 2004
Construction of an infectious HIV type 1 molecular clone from an African patient with a subtype D/C Recombinant VirusBinshan Shi, Sean M Philpott, Barbara Weiser, et al.
Trials|January 27, 2022
Vitamin D<sub>3</sub> and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trialNyasha Veronica Dzavakwa, Molly Chisenga, Grace McHugh, et al.
Trials|July 22, 2024
Update: Vitamin D<sub>3</sub> and calcium carbonate supplementation for adolescents with HIV to reduce musculoskeletal morbidity and immunopathology (VITALITY trial): study protocol for a randomised placebo-controlled trialNyasha Veronica Dzavakwa, Molly Chisenga, Grace McHugh, et al.
Virology Journal|January 30, 2021
Role of antenatal plasma cytomegalovirus DNA levels on pregnancy outcome and HIV-1 vertical transmission among mothers in the University of Zimbabwe birth cohort study (UZBCS)Kerina Duri, Simbarashe Chimhuya, Exnevia Gomo, et al.
Vaccine|September 24, 2005
Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteersInese Cebere, Lucy Dorrell, Helen McShane, et al.
Pageof 16